JSJennifer Sargent

Jennifer Sargent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jennifer Sargent has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predictors, patterns and outcomes following Infective endocarditis and stroke.

    by Ajay Kumar Mishra, Kamal Kant Sahu, Benson Mathew Abraham, Jennifer Sargent, Mark J Kranis, Susan V George, George Abraham

    Patients with infective endocarditis can have multiple neurological manifestations. Cerebrovascular events (CVE) in patients with IE can be hemorrhagic or embolic. Multiple factors are known to predispose to CVE and increased mortality in patients with IE. In this study, we aimed to describe various outcomes among patients with IE and CVE. We retrospectively analyzed 160 patients with definite IE. Among these, patients with radiological evidence of CVE were included. Clinical, radiological, echocardiographic details were obtained. Outcome studied were the requirement of intensive care unit care, the requirement of mechanical ventilation, prolonged course of antibiotics, prolonged duration of hospital stay, the requirement of surgical intervention, and mortality. In this study, 16 [10%] of patients with IE were identified to have a CVE. The mean age of the patients was 55, and 87.5% of them were male. 25% of patients had prior IE. IE involving left-sided valves were predominant, with the involvement of mitral valve reported in 62.5% of patients. More than half of the patient's had details of magnetic resonance imaging (MRI) of the brain. CVE were mostly ischemic, anterior circulation predominant, multiple, and bilateral. In patients with IE and CVE morbidity including the requirement of ICU care, prolonged antibiotics course, and the requirement of surgical intervention contributed to increased duration of hospital stay. In conclusion, CVE in patients with IE tends to present as multiple infarcts predominantly located over anterior circulation. IE patients with CVE tend to have higher morbidity and mortality.


  • Acquired Acrodermatitis Enteropathica

    by Anu Anna George, Ajay Kumar Mishra, Kamal Kant Sahu, Jennifer Sargent


  • Open Access

    An Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19).

    by Ajay Mishra, Amos Lal, Kamal Kant Sahu, Anu Anna George, Kevin Martin, Jennifer Sargent

    Coronavirus 19 disease (COVID-19) continues to be a pandemic with global implications. Respiratory system involvement is the most common manifestation in symptomatic patients. In this literature review, we describe the diagnosis, management, and implications of pulmonary hypertension (PH) among patients with COVID-19. We defined pulmonary hypertension as increasing mean pulmonary artery pressure (mPAP) of ≥ 25 mm Hg at rest. In our literature search, we identified 4 articles with details on pulmonary hypertension. Among these, two reported various echocardiographic details for diagnosing pulmonary hypertension. In 1 study evidence of pulmonary hypertension was noted in 13.4% of patients. Patients with severe COVID-19 were reported to have a higher proportion of pulmonary hypertension as compared to mild COVID-19 disease [22% vs 2%]. Elevated pulmonary artery systolic pressure was significant in predicting mortality. COVID-19 patients with chronic obstructive pulmonary disease, congestive heart failure, myocardial injury, pulmonary embolism, and prior pulmonary hypertension were at a higher risk of worsening pulmonary hypertension. Multiple mechanisms for developing pulmonary hypertension that have been postulated are i) concomitant worsening myocardial injury, ii) cytokine storm, endothelial injury, hypercoagulability attributing to development of venous thromboembolism, iii) and the presence of thrombotic microangiopathy. Among patients with severe COVID-19 disease and pulmonary hypertension, complications including acute respiratory distress syndrome, acute myocardial injury, the requirement of intensive care unit admission, the requirement of mechanical ventilation, and mortality are higher.


  • Open Access

    Mechanisms of stroke and the role of anticoagulants in COVID-19

    by Ajay Kumar Mishra, Kamal Kant Sahu, Amos Lal, Jennifer Sargent


  • Cardiovascular factors predicting poor outcome in COVID-19 patients

    by Ajay Kumar Mishra, Amos Lal, Kamal Kant Sahu, Jennifer Sargent


  • Open Access

    Quantifying and reporting cardiac findings in imaging of COVID-19 patients

    by Ajay Kumar Mishra, Amos Lal, Kamal Kant Sahu, Mark Kranis, Jennifer Sargent

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to be a public health emergency and a pandemic of international concern. As of April 31st, the reported cases of COVID-19 are three million in 186 countries. Reported case fatality has crossed 200 thousand among which more than fifty thousand has been in the USA. Most patients present with symptoms of fever, cough, and shortness of breath following exposure to other COVID-19 patients. Respiratory manifestations predominate in patients with mild, moderate, severe illness. Imaging of patients with COVID-19 consistently reports various pulmonary parenchymal involvement. In this article we wanted to reinforce and review the various reported imaging patterns of cardiac and mediastinal involvement in COVID-19 patients. Among patients with COVID 19 who underwent various imaging of chest various cardiac findings including pericardial effusion, myocarditis, cardiomegaly has been reported. Most of these findings have been consistently reported in patients with significant acute myocardial injury, and fulminant myocarditis. Acute biventricular dysfunction has also been reported with subsequent improvement of the same following clinical improvement. Details of cardiac MRI is rather limited. In a patient with clinical presentation of acute myocarditis, biventricular myocardial interstitial edema, diffuse biventricular hypokinesia, increased ventricular wall thickness, and severe LV dysfunction has been reported. Among patients with significant clinical improvement in LV structure and function has also been documented. With increasing number of clinical cases, future imaging studies will be instrumental in identifying the various cardiac manifestations, and their relation to clinical outcome.


  • Open Access

    Cerebrovascular events in COVID-19 patients

    by Ajay Kumar Mishra, Kamal Kant Sahu, Anu Anna George, Jennifer Sargent, Amos Lal

    Neurological manifestations in patients with COVID–19 are more frequently being reported. Cerebrovascular events have been reported in around 3% of patients. In this review we summarize the published literature on cerebrovascular events in patients with COVID-19 as available on the PubMed database. So far, 3 studies have reported cerebrovascular events. Cerebrovascular events were identified on screening patients with decreased consciousness or in the presence of focal neurological deficits. These events were common in elderly, critically ill patients and in patients with prior cardio-cerebrovascular comorbidities. The diagnosis of cerebrovascular events was confirmed with computed tomography of the brain in most studies reporting neurological events. Multiple pathological mechanisms have been postulated regarding the process of neurological and vascular injury among which cytokine storm is shown to correlate with mortality. Patients with severe illness are found to have a higher cardio- cerebrovascular comorbidity. With an increasing number of cases and future prospective studies, the exact mechanism by which these cerebrovascular events occur and attribute to the poor outcome will be better understood.